Tobacco Institute
3rd World Conference on Smoking and Health
Fields
Annotations
- 1. American Cancer Society Author
- Affiliation:
American Cancer Society
- Affiliation:
- 2. National Cancer Institute Usa Author
- Affiliation:
National Cancer Institute USA
- Affiliation:
Document Images
TgMIS 449694

"The purpose of the 3rd World Conference on
Smoking and Health is: to assess the trends in
smoking around the world; to assess the meas-
ures which have been employed to curb smok-
ing and safeguard the health of the population
from the hazards of smoking; and, then, to pro-
pose ways to advance the effectiveness of these
measures to the highest levels possible."
3rd World Conference on Smoking and Health
Planning Committee September 27, 1973
TIMN 449695

3rd World Conference
on Smoking and Health
Sponsored by
American Cancer Society
National Cancer Institute (U.S.A.)
In cooperation with:
American Heart Association
American Lung Association
American Medical Association
Health Education Council (UK)
International Union Against Cancer
National Cancer Institute of Canada
National Clearinghouse for Smoking and Health (USA )
National Heart and Lung Institute ( USA )
National Interagency Council on Smoking and Health ( USA )
Pan American Health Organization
World Health Organization
Waldorf-Astoria Hotel
New York City
June 2-5,1975
TIMN 449696

3rd World Conference
on Smoking and Health
Chairman: Sir George E. Godber, G.C.B., D.M., F.R.C.P.
Planning Committee
Dr. David T. Carr, Chairman
Dr. Mikhail A. Akhmeteli
Dr. Stephen M. Ayres
Dr. Sol R. Baker
Dr. William Carlyon
Dr. Charles M. Fletcher
Mr. Emerson Foote
Dr. Donald T. Fredrickson
Dr. Gio B. Gori
Dr. E. Cuyler Hammond
Dr. Daniel Horn
Mr. Walter G. James
Dr. Daniel J. Joly
Mr. Harry Milt, Coordinator
Dr. Donald C. Kent
Dr. Claude Lenfant
Mr. Sol S. Lifson
Dr. A. Helen Martikainen
Dr. Alton Ochsner, Jr.
Mr. Clifton Read
Mr. Irving I. Rimer
Mr. Roger W. Schmidt
Dr. Jesse L. Steinfeld
Dr. Robert M. Taylor
Dr. Luther L. Terry
Dr. A. P. Woudenberg
Dr. Ernst L. Wynder
2

Conference Format
The conference will begin 9:30 Monday morning, June
2, and end at noon Thursday, June 5.
All sessions and functions will be held in the Waldorf
Astoria Hotel.
The conference will open in a plenary session for all par-
ticipants, Monday morning, June 2.
Monday afternoon, the conference will break into five
separate sections, running concurrently and independ-
ently, through Wednesday afternoon, June 4.:
Section I-liealth Consequences of Smoking (p. 6)
Section II -Modifying the Risk (p. 9)
Section III-Education on Smoking (p. 12)
Section IV-Cessation Programs (p. 16)
Section V -Governmental and Social Action (p. 19)
Thursday morning, June 5, the five sections will disband,
and all participants will come together for the closing
plenary session.
Each participant has been asked to designate the section
to which he or she would prefer to be assigned; also, to
list second choices. In all but a very few cases, the first
choice has been honored. TO AVOID CONFUSION
AND DISORGANIZATION, CONFEREES ARE
URGED TO REMAIN WITH THE SECTION TO
WHICH THEY HAVE BEEN ASSIGNED: .
In addition to the working sessions, there will also be two
general functions:
An informal reception, Monday evening, June 2.
A luncheon Tuesday, June 3, at which the special guests
will be the Advisory Committee to the Surgeon General,
U.S. Public Health Service, and the Surgeon General,
authors and sponsor of the historic report in 1964,
SMOKING AND HEALTH.
3
TIMN 449698

3rd World Conference
on Smoking and Health
Opening Plenary Session
9:30 a.m., June 2
The Grand Ballroom
Chairman: Sir George E. Godber, G.C.B., D.M., F.R.C.P.
Call to order
Opening address
David T. Carr, M.D.
Theodore Cooper, M.D.
Assistant Secretary
for Health,
Department of Health,
Education and Welfare
Greetings
Greetings
Response
Introduction of Cooperating
Organizations
Address: The Hazards of Smok-
ing; The Benefits of Stopping-
The Scientific Evidence to Date.
Address: The Worldwide Cam-
paign Against Smoking
Address: Smoking and Health
Conference Procedure
Guy R. Newell, M.D.
Deputy Director
National Cancer Institute
Lane W. Adams
Executive Vice President
American Cancer Society
Alton Ochsner, M.D.
By the Chairman
Jesse L. Steinfeld, M.D.
Sir George E. Godber
Thomas Nesbitt, M.D.
Speaker, House of
Delegates
American Medical
Association
David T. Carr, M.D.
5
TIMN 449699

Section I
Health Consequences of Smoking
This section will open with a general session Monday
afternoon, June 2, in which review papers will be given
on the effects of smoking in relation to cancer, pulmo-
nary disease, cardiovascular disease, pregnancy, the pas-
sive smoker, and the benefits of stopping.
Tuesday morning, June 3, this section will divide into
sub-sections.
The sub-section on Smoking and Cancer will have ses-
sions Tuesday morning and afternoon, June 3, and
Wednesday morning, June 4.
The sub-section on Smoking and Pulmonary Disease will
have sessions Tuesday morning and Tuesday afternoon,
June 3.
The sub-section on Smoking and Cardiovascular Disease
will have one session Wednesday morning, June 4.
The sub-section on Smoking and Pregnancy will have
one session Wednesday morning, June 4.
There will be no separate sessions on the Benefits of
Stopping or on the Passive Smoker.
On Wednesday afternoon, June 4, the entire section on
Health Consequences of Smoking will reconvene for
evaluation, summary and recommendations.
Thursday morning, June 5, all sections will come to-
gether for the closing plenary session of the entire
conference.
Monday June 2 General Session: REVIEW OF RESEARCH
1:30 to 5:00 Chairman: Jesse L. Steinfeld
Hilton Room
6
1. Consequences of Smoking: Cancer. E. Cuyler Ham-
mond
2. Consequences of Smoking: Pulmonary Disease.
Charles M. Fletcher
3. Consequences of Smoking: Cardiovascular Disease.
Jeremiah Stamler
4. Consequences of Smoking: Pregnancy. Neville R.
Butler
5. Consequences of Smoking: The Passive Smoker.
David M. Burns
6. Benefits of Stopping: Daniel Horn
TIMN 449700

TuesdayJune3 Sub-Section A: SMOKING AND CANCER
9:00 to 12:00 Chairman: E. Cuyler Hammond
Hilton Room
Studies on the Lung
1. Overview: Impact of smoking on the occurrence of
" cancer. E. Cuyler Hammond
2. Japanese study: Smoking in relation to death rates
from cancer. Takeshi Hirayama
3. Epidemiological evidence on relation between smok-
ing habits and lung cancer. Marvin A. Schneiderman
4. Smoking in relation to histologic changes in bronchial
epithelium. Oscar Auerbach
2:30 to 5:30 5. Cytological changes in relation to smoking. Geno
Hilton Room Saccomanno
6. Discussion of evidence on smoking and lung cancer.
N. N. Napalkov
Sites Other Than Lung
1. Smoking in relation to cancer of the mouth, tongue
and lip. Condict Moore
2. Smoking in relation to cancer of pharynx, larynx,
esophagus, bladder and other sites, except lung. Ernst
L. Wynder
Wednesday June 4 General and Theoretical
9:00 to 12:00 1. Multiple factor interaction. Irving J. Selikoff
Hilton Room 2. Dosage factor (age began, amount, inhalation). E.
Cuyler Hammond
3. Effects of giving up smoking. Lawre:pce Garfinkel
4. What additional information would., be useful. Panel:
Gio B. Gori, Chairman
TuesdayJune 3 Sub-Section B: SMOKING AND PULMONARY
9:00 to 12:00 DISEASE
Basildon Room Chairman: Charles M. Fletcher
1. Smoking and lung function: epidemiological evidence.
Benjamin G. Ferris
2. Smoking and lung function: laboratory evidence. D.
V. Bates
3. Smoking and bronchial clearance. Michael T. New-
house
2:30 to 5:30 Chairman: Oscar Auerbach
Basildon Room
4. Experimental and human pathology (pulmonary) in
relation to smoking. Oscar Auerbach
5. Acute and chronic smoking inhalation studies in rats.
Paul Nettesheim
6. Evidence for pre-clinical lesions in lungs of early
smokers. Jerome I. Kleinerman
7
TIMN 449701

Wednesday June 4
9:00 to 12:00
Starlight Roof
North Terrace
Wednesday June 4
9:00 to 12:00
Starlight Roof
South Terrace
Sub-Section C: SMOKING AND
CARDIOVASCULAR DISEASE
Chairman: Jeremiah Stamler
1. Epidemiological studies in the United States on smok-
ing and coronary heart disease. Jeremiah Stamler
2. Epidemiological studies in the United Kingdom on
smoking and coronary heart disease. Donald D. Reid
3. Studies in Scandinavia and Western European coun-
tries. Lars Wilhelmsen
4. Studies in Poland and other Eastern European coun-
tries. Kornel Gibinski
5. Studies in Japan. Noboru Kimura
6. Epidemiological studies on smoking and cerebral vas-
cular and peripheral disease. William B. Kannel
7. Studies on carbon monoxide, thiocyanide and nico-
tine. Poul Astrup
Sub-Section D: SMOKING AND PREGNANCY
Chairman: Neville R. Butler
1. Epidemiological considerations. Neville R. Butler
2. Intrauterine studies-effect on fetal breathing. Geof-
frey S. Dawes
3. Statistical aspects. Harvey Goldstein
4. Physiological studies. Lawrence D. Longo
Wednesday June 4 General Session, Section 1: EVALUATION AND
2:00 to 5:00 SUMMARY
Chairman: Jesse L. Steinfeld
Thursday June 5
9:00 to 12:00
Empire Room
8
1. Benefits of stopping. Leonard M. Schuman
2. Health consequences: cancer. E. Cuyler Hammond
3. Health consequences: pulmonary. Charles M. Fletcher
4. Health consequences: cardiovascular. Jeremiah Stam-
ler
5. Health consequences: pregnancy. Neville R. Butler
Closing Plenary Session for the Entire Conference
Chairman: Sir George E. Godber
Report of recommendation from each of the five sections
and adoption of recommendations.
,
TIMN 449702

Section tl
Modifying The Risk To The Smoker
This section will open with a general session on Monday
afternoon, June 2 in which there will be reports and dis-
cussion of general problems and opportunities related to
the less harmful cigarette.
Tuesday morning and afternoon, June 3, there will be
three sub-sections running concurrently, with reports and
discussion on the ways in which the particular ingredients
of tobacco smoke are related to disease in different or-
gans and systems: cancer, cardiovascular disease, and
chronic pulmonary disease.
Wednesday morning, June 4, the section will reassemble
in general session for reports and discussion on the tech-
nolbgical aspects of our ability to reduce specific com-
ponents of cigarette smoke; also the factor of public
acceptance of these reductions.
Wednesday afternoon, June 4, the section will meet again
in general session to hear and discuss recommendations
on modifying the risk.
Thursday morning, June 5, all sections will come together
for the closing plenary session of the entire conference.
Monday June 2 General Session: PROBLEMS AND
1:30 to 5:30 OPPORTUNITIES
Jade Room Chairman: Ernst L. Wynder
1. Relative risks of cigarette-related disease by type of
cigarette smoked. Ernst L. Wynder
2. The physiochemical nature of tobacco smoke. Irwin
Schmeltz
3. Methods for reduction of tar and nicotine levels in
tobacco and in cigarettes.
a. Agricultural techniques. T. C. Tso
b. Filtration techniques. Charles M. Keith
c. Tobacco modifications. Howard M. Halter
d. Tobacco modifications. Bryan F. Zilkey
e. Particle size. Friedlieb Seehofer.
f. Reconstituted sheets. William A. Selke
4. Reduction of tar and nicotine levels in different coun-
tries during the last two decades.
a. U.S.A. Thomas B. Owen
b. United Kingdom. Donald D. Reid
c. Germany. Dietrich Schmahl
d. Austria. Hans Kuhn
e. Sweden. Lasse O. Hjern
f. Canada. Winston H. Cherry
5. Less harmful ways of smoking. (Risk related to cigar/
pipe smoking, inhalation, butt end, etc.).
a. Epidemiological data. Irwin D. Bross
9
TIMN 449703
